Tech Company Financing Transactions
Mironid Funding Round
BioGeneration Ventures, Epidarex Capital and Roche Venture Fund participated in a $46 million Series B funding round for Mironid. The round was announced by the company on 8/5/2026.
Transaction Overview
Company Name
Announced On
8/5/2026
Transaction Type
Venture Equity
Amount
$46,000,000
Round
Series B
Investors
Proceeds Purpose
This financing will allow us to progress the clinical development of our lead candidate, bringing us closer to transforming the treatment landscape for patients with rare kidney diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Arbuthnott Building -- Hamnett Wing, 161 Cathedral Street
Glasgow, Scotland, G4 0RE
UK
Glasgow, Scotland, G4 0RE
UK
Phone
Undisclosed
Website
Email Address
Overview
Mironid is a vibrant, growing, patient focused company with an outstanding team motivated to deliver innovative new medicines. We aim to improve the health and quality of life of patients by creating high value therapeutics addressing global unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Neil Wilkie
Browse more venture capital transactions:
Prev: 8/5/2026: Multiplier venture capital transaction
Next: 8/5/2026: Wellinks venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs